27.92
0.50 (1.82%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Waste Management (US) | Bullish | Bullish |
| Waste Management (Global) | Bullish | Mixed | |
| Stock | Janus Living, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 1.00 |
|
JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company’s goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations. |
|
| Sector | Industrials |
| Industry | Waste Management |
| Investment Style | Small Value |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Prudential Financial Inc | 31 Mar 2026 | 3,317,262 |
| Long Pond Capital, Lp | 31 Mar 2026 | 3,290,000 |
| Centersquare Investment Management Llc | 31 Mar 2026 | 1,980,000 |
| Cbre Investment Management Listed Real Assets Llc | 31 Mar 2026 | 527,940 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |